GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human arc ctd in complex with two anti-arc nanobodies

Analyse Crystal structure of human arc ctd in complex with two anti-arc nanobodies in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7R23
Type
protein
Length
388 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Arc; Chains: B; Chains: C
UniProt
A0A3L7I2Q1
Pockets
3 · best druggability 0.50

Structure

x-ray diffraction · 3 distinct chains · 30% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AArcprotein14569% helix, 0% strandA0A3L7I2Q1
BChains: Bprotein1247% helix, 44% strand—
CChains: Cprotein1195% helix, 52% strand—

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12590.500.7427empty
2720.360.7715empty
3800.350.7618empty

Interfaces

2 interfaces between chains.

  • A–B · 1056 Ų buried · 10 hydrogen bonds · protein-protein
  • A–C · 847 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 7R23 · Crystal structure of human Arc CTD in complex with two anti-Arc nanobodies · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.